What is Advanced Analytical Laboratory?
Advanced Analytical Laboratory operates as a specialized service provider focused on the qualification of Active Pharmaceutical Ingredients (API) and excipients. The firm offers a comprehensive suite of analytical services, including residual solvent testing, potency assays, and impurity profiling, all conducted in strict adherence to USP standards. Their facility is equipped with advanced instrumentation, such as HPLC and GC systems with headspace units, FTIR spectrophotometers, and dissolution apparatus, enabling high-precision quantitative and qualitative analysis.
By providing essential data for finished product release and raw material identification, the laboratory serves as a vital link in the pharmaceutical supply chain. Their technical expertise in areas like TOC analysis, Karl Fischer titrations, and viscometry ensures that clients meet the stringent safety and efficacy requirements mandated by global health authorities.
How much funding has Advanced Analytical Laboratory raised?
Advanced Analytical Laboratory has raised a total of $323K across 2 funding rounds:
Debt
$150K
Debt
$173K
Debt (2020): $150K with participation from PPP
Debt (2021): $173K led by PPP
Key Investors in Advanced Analytical Laboratory
PPP
Public-Private Partnership
What's next for Advanced Analytical Laboratory?
With this late-stage funding, Advanced Analytical Laboratory is expected to prioritize the modernization of its analytical suite and the expansion of its testing throughput. The strategic focus will likely center on enhancing laboratory automation and increasing capacity for complex solid dosage drug release studies. As the pharmaceutical industry faces increasing pressure to accelerate time-to-market while maintaining uncompromising quality, the company is well-positioned to capture additional market share through its specialized testing infrastructure and commitment to regulatory excellence.
See full Advanced Analytical Laboratory company page
